NEOGENOMICS
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
NEOGENOMICS
Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical Pharmaceutical
Founded:
1998-10-29
Address:
Fort Myers, Florida, United States
Country:
United States
Website Url:
http://www.neogenomics.com
Total Employee:
501+
Status:
Active
Contact:
(239) 768-0600
Email Addresses:
[email protected]
Total Funding:
350.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Nginx Amazon ReCAPTCHA
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cure Forward
Cure Forward helps cancer patients and physicians access advanced treatments in oncology.
Gravity Diagnostics
Gravity Diagnostics is a full-service state-of-the-art CLIA laboratory licensed in all 50 states providing innovative laboratory testing.
IceCure Medical Ltd.
IceCure is a medical device company setting new standards in minimally-invasive tumor therapy women’s health and interventional oncology.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Vireo Health
Vireo Health is a medical marijuana dispensary.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-05 | Inivata | Inivata acquired by NeoGenomics | N/A |
| 2021-03-24 | Trapelo Health | Trapelo Health acquired by NeoGenomics | 65 M USD |
| 2018-10-23 | Genoptix | Genoptix acquired by NeoGenomics | N/A |
| 2015-10-21 | Clarient | Clarient acquired by NeoGenomics | N/A |
| 2014-07-08 | Path Logic | Path Logic acquired by NeoGenomics | 6 M USD |
Investors List
Woodline Partners
Woodline Partners investment in Post-IPO Equity - NeoGenomics
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - NeoGenomics
Blue Water Life Science Fund
Blue Water Life Science Fund investment in Post-IPO Equity - NeoGenomics
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - NeoGenomics
Soleus Capital
Soleus Capital investment in Post-IPO Equity - NeoGenomics
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - NeoGenomics
First Light Asset Management
First Light Asset Management investment in Post-IPO Equity - NeoGenomics
Janus Henderson Investors
Janus Henderson Investors investment in Post-IPO Equity - NeoGenomics
Pura Vida Investments
Pura Vida Investments investment in Post-IPO Equity - NeoGenomics
Casdin Capital
Casdin Capital investment in Post-IPO Equity - NeoGenomics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-05-26 | Inivata | NeoGenomics investment in Corporate Round - Inivata | 25 M USD |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.neogenomics.com Semrush global rank: 583 K Semrush visits lastest month: 79.21 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NeoGenomics" on Search Engine
Our Team | NeoGenomics Laboratories
Through our expertise, customization, and scalability, NeoGenomics supports clients in cancer-related market segments, including hospital and private pathology laboratories, office-based oncologists, academic …See details»
NeoGenomics - Wikipedia
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.See details»
Executive Team :: NeoGenomics, Inc. (NEO)
Executive Team :: NeoGenomics, Inc. (NEO) Chris Smith. Chief Executive Officer. Chris joins NeoGenomics from OrthoClinical Diagnostics where he served as Chairman and …See details»
NeoGenomics Company Overview
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with …See details»
Our History | NeoGenomics Laboratories
About. Our History. Nearly 20 years of transforming care for cancer patients. NeoGenomics has evolved through the years but our commitment to our clients and the patients they serve will never change. 2:18. …See details»
Board of Directors :: NeoGenomics, Inc. (NEO)
Neil Gunn. Board Member. Neil Gunn is a veteran Diagnostics senior executive with expertise in company organization to maximize efficiencies with a focus on value …See details»
NeoGenomics Laboratories | LinkedIn
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world …See details»
NeoGenomics Reports First Quarter 2024 Results
Apr 30, 2024 FORT MYERS, Fla.-- (BUSINESS WIRE)-- NeoGenomics, Inc. (NASDAQ: NEO) (the “ Company ”), a leading provider of oncology testing and global contract …See details»
NeoGenomics, Inc. Expands Its Global Strategic Partnership …
Apr 11, 2022 FORT MYERS, FL / ACCESSWIRE / April 11, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research …See details»
NeoGenomics, Inc. Expands Its Global Strategic Partnership
Apr 11, 2022 FORT MYERS, FL / ACCESSWIRE / April 11, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research …See details»
ConcertAI & NeoGenomics Announce Collaboration to Advance …
CAMBRIDGE, Mass., January 8, 2023 — /PRNewswire/ ConcertAI, LLC, a leading oncology real-world evidence data and AI technology company, and NeoGenomics, Inc., …See details»
NeoGenomics Showcases Commitment to Transforming Cancer …
Mar 27, 2024 MYERS, Fla.-- (BUSINESS WIRE)-- NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, alongside research collaborators, will …See details»
NeoGenomics Expands Board of Directors with Appointments of …
Jun 29, 2023 MYERS, FL / ACCESSWIRE / June 29, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research …See details»
NeoGenomics - Funding, Financials, Valuation & Investors
NeoGenomics has acquired 6 organizations. Their most recent acquisition was Inivata on May 5, 2021. Unlock for free. Funding Rounds. Number of Funding Rounds 7. Total …See details»
Massive Bio and NeoGenomics Announce Collaboration to …
Mar 22, 2023 NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in …See details»
Accelerating Oncology Drug Discovery - Massive Bio
Mar 22, 2023 MYERS, FL & NEW YORK, NY, March 22, 2023 – Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge …See details»
NeoGenomics Announces Senior Leadership Promotions
MYERS, Fla., April 18, 2024 -- ( BUSINESS WIRE )-- NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced two promotions within …See details»
NeoGenomics Reports First Quarter 2024 Results - Yahoo Finance
FORT MYERS, Fla., April 30, 2024 -- ( BUSINESS WIRE )-- NeoGenomics, Inc. (NASDAQ: NEO) (the " Company "), a leading provider of oncology testing and global contract …See details»
NeoGenomics Laboratories hiring Head of Organizational
NeoGenomics is looking for a Head of Organization Development who wants to continue to learn in order to allow our company to grow. This opportunity is open as a fully remote …See details»
Neogenomics general counsel Alicia C. Olivo sells over $16k in …
2 days ago NEO. -1.27%. Neogenomics Inc's (NASDAQ:NEO) General Counsel, Alicia C. Olivo, has recently sold shares of the company's stock, according to a new SEC filing. …See details»